FIELD: medicine.
SUBSTANCE: invention discloses an immunogen for treating and preventing opiate dependence differing by the fact that the immunogen is presented by polyclonal anti-idiotope (secondary) antibodies to opiates, namely to morphine and its derivatives.
EFFECT: immunogen is promising for treating and prevention the addiction in the individuals misusing opiates, such as morphine and its derivatives, particularly heroin and codeine.
6 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-K11B, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2020 |
|
RU2745374C1 |
| MONOCLONAL ANTIBODY 6G1 TO MORPHINE DERIVATIVES | 2018 |
|
RU2703494C1 |
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AI-G1, HAVING ANTIGENIC PROPERTIES OF MORPHINE | 2019 |
|
RU2717989C1 |
| SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2643329C1 |
| SYNTHETIC IMMUNOGEN FOR PROTECTION AGAINST TOXIC ACTION OF NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2012 |
|
RU2526807C2 |
| SYNTHETIC IMMUNOGEN FOR PROTECTION AND TREATMENT OF PSYCHOACTIVE SUBSTANCES ADDICTION | 2016 |
|
RU2635517C1 |
| SYNTHETIC IMMUNOGEN FOR THERAPY AND PROPHYLAXIS OF ADDICTION WITH NARCOTIC AND PSYCHOACTIVE SUBSTANCES | 2003 |
|
RU2236257C1 |
| AGENT USED IN PROPHYLAXIS AND TREATMENT OF OPIOMANIA | 2002 |
|
RU2264228C2 |
| MONOCLONAL ANTIBODY 3K11 TO MORPHINE DERIVATIVES | 2018 |
|
RU2702002C1 |
| IMMUNOMIMETIC PEPTIDE OF CHEMICAL CANCEROGENS WITH SPECIFIC INTERACTION EFFECT ON ANTIBODIES OF BENZO[α]PYRENE AND BENZO[α]ANTHRACENE | 2007 |
|
RU2357975C1 |
